Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for autoimmune and rare diseases, today ...

Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced its intention to offer, subject to market and other conditions, $400 million aggregate principal amount of convertible senior notes due 2032 ...

(“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced its intention to offer, subject to market conditions and other ...

Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN) today announced the pricing of $115 million aggregate principal amount of 6.75% Convertible Senior Notes due 2034 (the “notes”) in a private offering (the ...

An announcement from Ocugen ( (OCGN)) is now available. On May 4, 2026, Ocugen announced a private offering of convertible notes, including an option for the initial purchaser to buy up to an ...

ProPetro Holding (NYSE:PUMP) shares fell 6% Monday after the company announced plans to offer $500 million in convertible senior notes due 2031 in a private place ...

Amkor Technology (AMKR) has priced its private offering of $1B aggregate principal amount of 0.00% convertible senior notes due 2031. The sale is scheduled to settle on May 5, 2026, subject to ...

ProPetro has priced a $600 million private offering of 0.00% convertible senior notes due 2031, up from an initial $500 million plan. Proceeds will fund capped call transactions to limit dilution and ...

In addition, to secure the transactions and as a condition precedent to the Closing, the Company, its subsidiaries, and the Investor also entered into a Guarantee Agreement at the Closing to guarantee ...

Ocugen shares fell over 19% on Tuesday after the biotech’s net losses widened in Q1. Net loss for the quarter was $19.17M, compared to a $15.35M loss in the same period last yea ...

Q1 2026 earnings call highlights: improving Permian sand/logistics, 120MW PPA, 1.4GW Cat deal, Q2 EBITDA outlook—read now.

Ocugen, Inc. (NASDAQ:OCGN) shares fell 17% Tuesday following the announcement of a $115 million convertible senior notes offering priced at a significant discount ...